Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127740822 | 12774082 | 2 | F | 20160913 | 20160923 | 20160923 | EXP | AU-APOTEX-2016AP012186 | APOTEX | NGUYEN TA, CAUGHEY G, PRATT N, SHAKIB S, KEMP A, ROUGHEAD E.. HOSPITALIZATION FOR DRUG-INDUCED HEPATOTOXICITY: LINKING Y-CODES WITH PHARMACEUTICAL CLAIMS DATA TO IDENTIFY IMPLICATED MEDICINES.. J-CLIN-PHARM-THER. 2015;40(2):213-219 | 0.00 | Y | 0.00000 | 20160923 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127740822 | 12774082 | 1 | SS | CEFALEXIN | CEPHALEXIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127740822 | 12774082 | 2 | SS | APO-ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | U | U | 0 | TABLET | |||||||
| 127740822 | 12774082 | 3 | SS | APO-ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | U | 0 | TABLET | ||||||||
| 127740822 | 12774082 | 4 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127740822 | 12774082 | 5 | SS | IRBESARTAN. | IRBESARTAN | 1 | Unknown | UNK | U | U | 0 | TABLET | |||||||
| 127740822 | 12774082 | 6 | PS | GENRX ALLOPURINOL | ALLOPURINOL | 1 | Unknown | UNK | U | U | 77353 | TABLET | |||||||
| 127740822 | 12774082 | 7 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | UNK | U | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127740822 | 12774082 | 1 | Product used for unknown indication |
| 127740822 | 12774082 | 2 | Hyperlipidaemia |
| 127740822 | 12774082 | 3 | Arteriosclerosis |
| 127740822 | 12774082 | 4 | Product used for unknown indication |
| 127740822 | 12774082 | 5 | Product used for unknown indication |
| 127740822 | 12774082 | 6 | Product used for unknown indication |
| 127740822 | 12774082 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127740822 | 12774082 | OT |
| 127740822 | 12774082 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127740822 | 12774082 | Drug-induced liver injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |